The Annual Sickle Cell Disease Therapeutics Conference is a forum to discuss the latest advancements and future trends for treating patients with sickle cell disease. Conference attendees will hear presentations from clinical-stage companies, key opinion leaders, patients and healthcare analysts. View the most recent Event Schedule.
The 5th Annual Sickle Cell Disease Therapeutics Conference will be held in the Cosmopolitan Suite of the Four Seasons Hotel in New York on September 8, 2016.
Panelists
- Miguel R. Abboud, MD – Professor and Chairman, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
- Richard Drachtman, MD – Professor of Pediatrics and Clinical Section Chief, Pediatric Hematology Oncology, Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, Rutgers
- Julie Kanter-Washko, MD – Director Sickle Cell Disease Research and Assistant Professor, Medical University of South Carolina
- Claudia Morris, MD – Associate Professor Emergency Medicine Department of Pediatrics, Emory University School of Medicine
Patient Advocates
- Mary Brown – President, Sickle Cell Disease Foundation of California
- Gary Gibson – President & CEO, The Martin Center Sickle Cell Initiative
Moderating Analysts
- Michael Higgins – Senior Research Analyst, Roth Capital Partners
- Jason McCarthy Ph.D. – Equity Research Analyst, Maxim Group, LLC
- Edward Tenthoff – Senior Research Analyst, Piper Jaffray & Co.
The conference agenda has yet to be finalized, please check back later for more information.